Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sun

Showing results (1121-1130 of 1,142) with videos related to

Pageof 115
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2017
Allosteric "beta-blocker" isolated from a DNA-encoded small molecule librarySeungkirl Ahn, Alem W Kahsai, Biswaranjan Pani, et al.
Physical Review Letters|May 31, 2019
New Isotope ^{220}Np: Probing the Robustness of the N=126 Shell Closure in NeptuniumZ Y Zhang, Z G Gan, H B Yang, et al.
Cancer Research Communications|August 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid TumorsChristopher T Chen, Vishesh Khanna, Shivaani Kummar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 25, 2015
Epidemiology and characteristics of the dengue outbreak in Guangdong, Southern China, in 2014L Huang, X Luo, J Shao, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.
The British Journal of Dermatology|February 2, 2017
Multiple variants in 5q31.1 are associated with systemic lupus erythematosus susceptibility and subphenotypes in the Han Chinese populationL L Wen, Z W Zhu, C Yang, et al.
Chemmedchem|July 9, 2019
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular SafetyFrederick Cohen, James B Aggen, Logan D Andrews, et al.
Nature Communications|August 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trialBrittany N Flores, Seungyoon B Yu, Isaac V Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe diseaseJ E Horowitz, J A Kosmicki, A Damask, et al.
Pageof 115

Showing results (1121-1130 of 1,142) with videos related to

Sort By:
Pageof 115
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2017
Allosteric "beta-blocker" isolated from a DNA-encoded small molecule librarySeungkirl Ahn, Alem W Kahsai, Biswaranjan Pani, et al.
Physical Review Letters|May 31, 2019
New Isotope ^{220}Np: Probing the Robustness of the N=126 Shell Closure in NeptuniumZ Y Zhang, Z G Gan, H B Yang, et al.
Cancer Research Communications|August 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid TumorsChristopher T Chen, Vishesh Khanna, Shivaani Kummar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 25, 2015
Epidemiology and characteristics of the dengue outbreak in Guangdong, Southern China, in 2014L Huang, X Luo, J Shao, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.
The British Journal of Dermatology|February 2, 2017
Multiple variants in 5q31.1 are associated with systemic lupus erythematosus susceptibility and subphenotypes in the Han Chinese populationL L Wen, Z W Zhu, C Yang, et al.
Chemmedchem|July 9, 2019
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular SafetyFrederick Cohen, James B Aggen, Logan D Andrews, et al.
Nature Communications|August 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trialBrittany N Flores, Seungyoon B Yu, Isaac V Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe diseaseJ E Horowitz, J A Kosmicki, A Damask, et al.
Pageof 115